Vanguard Group Inc Ardelyx, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Ardelyx, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 18,369,321 shares of ARDX stock, worth $108 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,369,321
Previous 16,031,649 14.58%
Holding current value
$108 Million
Previous $62.8 Million 61.35%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$3.92 - $6.64 $9.16 Million - $15.5 Million
2,337,672 Added 14.58%
18,369,321 $101 Million
Q2 2025

Aug 11, 2025
BUY
$3.28 - $5.51 $3.39 Million - $5.7 Million
1,034,415 Added 6.9%
16,031,649 $62.8 Million
Q1 2025

May 09, 2025
BUY
$4.91 - $6.36 $3.12 Million - $4.04 Million
634,575 Added 4.42%
14,997,234 $73.6 Million
Q4 2024

Feb 11, 2025
BUY
$4.49 - $6.85 $3.44 Million - $5.25 Million
767,111 Added 5.64%
14,362,659 $74.3 Million
Q3 2024

Nov 13, 2024
SELL
$5.28 - $7.57 $318,378 - $456,463
-60,299 Reduced 0.44%
13,595,548 $93.7 Million
Q2 2024

Aug 13, 2024
BUY
$5.89 - $9.31 $1.55 Million - $2.46 Million
263,992 Added 1.97%
13,655,847 $101 Million
Q1 2024

May 10, 2024
BUY
$6.05 - $9.74 $2.21 Million - $3.56 Million
365,809 Added 2.81%
13,391,855 $97.8 Million
Q4 2023

Feb 14, 2024
BUY
$3.29 - $6.64 $4.8 Million - $9.7 Million
1,460,246 Added 12.63%
13,026,046 $80.8 Million
Q3 2023

Nov 14, 2023
BUY
$3.3 - $4.83 $323,238 - $473,103
97,951 Added 0.85%
11,565,800 $47.2 Million
Q2 2023

Aug 14, 2023
BUY
$3.23 - $4.95 $9.02 Million - $13.8 Million
2,793,144 Added 32.2%
11,467,849 $38.9 Million
Q1 2023

May 15, 2023
BUY
$2.68 - $4.79 $967,994 - $1.73 Million
361,192 Added 4.34%
8,674,705 $41.6 Million
Q4 2022

Feb 10, 2023
BUY
$1.22 - $2.85 $3.13 Million - $7.32 Million
2,567,995 Added 44.7%
8,313,513 $23.7 Million
Q3 2022

Nov 14, 2022
BUY
$0.59 - $1.44 $300,251 - $732,817
508,901 Added 9.72%
5,745,518 $6.84 Million
Q2 2022

Aug 12, 2022
BUY
$0.51 - $1.17 $665,848 - $1.53 Million
1,305,586 Added 33.21%
5,236,617 $3.09 Million
Q1 2022

May 13, 2022
SELL
$0.65 - $1.18 $321,943 - $584,451
-495,298 Reduced 11.19%
3,931,031 $4.21 Million
Q4 2021

Feb 14, 2022
BUY
$0.86 - $1.7 $397,992 - $786,729
462,782 Added 11.68%
4,426,329 $4.87 Million
Q3 2021

Nov 12, 2021
BUY
$1.27 - $8.17 $85,031 - $547,014
66,954 Added 1.72%
3,963,547 $5.23 Million
Q2 2021

Aug 13, 2021
BUY
$6.55 - $8.98 $25.5 Million - $35 Million
3,896,593 New
3,896,593 $29.5 Million

Others Institutions Holding ARDX

# of Institutions
244
Shares Held
161M
Call Options Held
697K
Put Options Held
1.61M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $908M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email